NCT05514080View on ClinicalTrials.gov

A Study to Evaluate Eli Lilly's Insulin Dosing Algorithm to Control Glycemia in Insulin-treated Adults With Type 2 Diabetes

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

December 6, 2019

Primary Completion Date

September 4, 2021

Study Completion Date

March 30, 2022

Conditions
Diabetes Mellitus, Type 2
Interventions
OTHER

Insulin closed-loop

41-hour intervention period in which the participants are treated with rapid insulin in the closed-loop system.

Trial Locations (1)

H4A 3J1

Centre for Innovative Medicine at McGill University Health Centre Research Institute, Montreal

All Listed Sponsors
lead

McGill University

OTHER

NCT05514080 - A Study to Evaluate Eli Lilly's Insulin Dosing Algorithm to Control Glycemia in Insulin-treated Adults With Type 2 Diabetes | Biotech Hunter | Biotech Hunter